Replaglinide is the active ingredient in an antidiabetic drug known commercially as Novonorm.
This oral medicinal product is indicated for the treatment of diabetes in people who are not dependent on insulin. The action of repaglinide consists of the release of insulin by the cells of the pancreas, thus regulating the concentration of blood sugar.
Type 2 diabetes mellitus
The 0. 5 mg can of Repaglinide containing 30 tablets costs approximately 55 reais, the 1 mg box containing 30 tablets costs approximately 67 reais and the 2 mg box containing 30 tablets costs approximately 78 reais.
Diarrhea; nausea back pain joint pain rhinitis; sinusitis; bronchitis; Skull pain.
Risk of pregnancy C; Women who breastfeed; Type 1 Diabetes Hypersensitivity to one of the components of the formula.
Oral
Adults (treated with other medicines)
Adults (not treated with another drug)